Recent advances in atypical antipsychotics
Armer, R.; Miller, D.J.
Current Opinion in Investigational Drugs 1(4): 481-493
2000
ISSN/ISBN: 1472-4472 PMID: 11249703 Document Number: 515444
Document emailed within 1 workday
Related Documents
Rollini, M.; Schulz, P. 2008: Atypical antipsychotics for elderly patients: to prescribe or to ban? Revue Medicale Suisse 4(153): 979Farver, D. 2007: The outpatient use of atypical antipsychotics with Alzheimer's disease South Dakota Medicine: the Journal of the South Dakota State Medical Association 60(3): 113; 115
Frecska, E. 2005: From cradle to grave? Expectations from atypical antipsychotics Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 7(1): 34-38
Findling, R.L. 2004: Atypical antipsychotics in the treatment of children and adolescents Journal of Clinical Psychiatry 65(Suppl): 3-4
Haberfellner, E.M.; Honsig, T. 2003: Nonalcoholic steatohepatitis: a possible side effect of atypical antipsychotics Journal of Clinical Psychiatry 64(7): 851
Glazer, W.M. 2000: Expected incidence of tardive dyskinesia associated with atypical antipsychotics Journal of Clinical Psychiatry 61(Suppl): 21-26
Splinter, G.; Nesser, N. 2012: OHCA supports docs with best practice for atypical antipsychotics Journal of the Oklahoma State Medical Association 105(8): 324-325
Tsygankov, B.D.; Agasarian, E.G. 2010: The comparative efficacy of therapy with typical and atypical antipsychotics Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(9): 83-86
Duggins, R.; Rhinds, D.; Hall, W. 2001: Atypical antipsychotics in the treatment of schizophrenia. Cost is a crucial issue Bmj 322(7291): 926; Author Reply 927-8
Czekalla, J.; Kollack-Walker, S.; Beasley, C.M. 2001: Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics Journal of Clinical Psychiatry 62(Suppl): 35-40
Agius, M.; Birtwhistle, M.; Servant, D.; Zaman, R. 2011: How frequently are atypical antipsychotics used to treat OCD in a British community mental health team? Psychiatria Danubina 23(Suppl 1): S187-S193
Taylor, D. 2001: Atypical antipsychotics in the treatment of schizophrenia. Pragmatic considerations are important when considering which drug to prescribe Bmj 322(7291): 925; Author Reply 927-8
Drummond, M..F..; Knapp, M..R.J..; Burns, T..P..; Shadwell, P.. 1998: Issues in the design of studies for the economic evaluation of new atypical antipsychotics: the ESTO study Journal of Mental Health Policy and Economics 1(1): 15-22
Verma, S.D.; Davidoff, D.A.; Kambhampati, K.K. 1998: Management of the agitated elderly patient in the nursing home: the role of the atypical antipsychotics Journal of Clinical Psychiatry 59(Suppl): 50-55
Szulc, A.; Galińiska, B.; Tarasów, E.; Dzienis, W.; Kubas, B.; Konarzewska, B.; Waszkiewicz, N.; Popławska, R. 2010: The influence of atypical antipsychotics on brain functioning in schizophrenia. a proton magnetic resonance study Psychiatria Polska 44(3): 415-426
Puri, B.K.; Davey, N.J.; Zaman, R. 2003: Excitability of the motor cortex in schizophrenia following typical and atypical antipsychotics: two serial case reports International Journal of Clinical Practice 57(9): 831-833
Lee, S. 2001: Atypical antipsychotics in the treatment of schizophrenia. "Informed relationship between doctor and patient" does not exist in many parts of the world Bmj 322(7291): 925
Meyer, P.S.; Bond, G.R.; Tunis, S.L.; McCoy, M.L. 2002: Comparison between the effects of atypical and traditional antipsychotics on work status for clients in a psychiatric rehabilitation program Journal of Clinical Psychiatry 63(2): 108-116
Gasquet, I.; Bouhassira, M.; Launois, R. 2005: Cost analysis of the strategies in the treatment of schizophrenics: the place of sustained release injectable atypical antipsychotics L'Encephale 31(4 Part 1): 517-518
Hrdlicka, M.; Zedkova, I.; Blatny, M.; Urbanek, T. 2009: Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study Neuro Endocrinology Letters 30(2): 256-261